Stockscreener 앱 받기
0.642
0.45%
0.0029
시간 외 거래:
.62
-0.022
-3.43%
전일 마감가:
$0.6391
열려 있는:
$0.6345
하루 거래량:
55,831
Relative Volume:
0.23
시가총액:
$66.76M
수익:
$1.29M
순이익/손실:
$-29.87M
주가수익비율:
-1.7833
EPS:
-0.36
순현금흐름:
$-14.70M
1주 성능:
+0.31%
1개월 성능:
-9.03%
6개월 성능:
+7.00%
1년 성능:
+12.63%
1일 변동 폭
$0.6201
$0.65
1주일 범위
$0.60
$0.68
52주 변동 폭
$0.3951
$0.94
VolitionRX Ltd Stock (VNRX) Company Profile
명칭
VolitionRX Ltd
전화
646 650 1351
주소
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
VNRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VNRX
VolitionRX Ltd
|
0.642 | 69.46M | 1.29M | -29.87M | -14.70M | -0.36 |
|
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-08 | 개시 | H.C. Wainwright | Buy |
| 2023-02-01 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-02-17 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-03-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-05-16 | 개시 | Maxim Group | Buy |
| 2018-05-14 | 재확인 | The Benchmark Company | Buy |
| 2016-09-07 | 재확인 | Rodman & Renshaw | Buy |
| 2016-02-01 | 개시 | Rodman & Renshaw | Buy |
모두보기
VolitionRX Ltd 주식(VNRX)의 최신 뉴스
What does recent volatility data suggest for VolitionRx LimitedReversal Pattern Insights with Entry Tips - Newser
Real time social sentiment graph for VolitionRx LimitedAI Enhanced Strategy for Portfolio Growth - Newser
How moving averages guide VolitionRx Limited tradingDaily Trade Setup Forecast with Confidence - Newser
Measuring VolitionRx Limited’s beta against major indicesStock Holding Strategy Long-Term Summary Sheet - Newser
What machine learning models say about VolitionRx LimitedBuy/Sell Zone Confirmation Technical Analysis - Newser
What risks could impact VolitionRx Limited stock performanceSwing Entry Insight With Forecast Accuracy - Newser
Visual analytics tools that track VolitionRx Limited performanceIntraday Strategy with Real Time Monitoring - Newser
Analyzing VolitionRx Limited with multi timeframe chartsDownside Control Plan With Support Analysis - Newser
Using AI based signals to follow VolitionRx LimitedEarly Buy Opportunity with Chart Triggers - Newser
VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering - 富途牛牛
What makes VolitionRx Limited stock price move sharplyTrade Alert System with Volume Analysis - Newser
Is it the right time to buy VolitionRx Limited stockInvest smarter with expert stock recommendations - Jammu Links News
Volatility clustering patterns for VolitionRx LimitedTrend Reversal Probability Forecast Update - Newser
What are the technical indicators suggesting about VolitionRx LimitedSkyrocketing investment returns - Jammu Links News
What are analysts’ price targets for VolitionRx Limited in the next 12 monthsGet high-impact stock recommendations now - Jammu Links News
What is the dividend policy of VolitionRx Limited stockMarket Forecast Review For 2025 - Jammu Links News
Combining machine learning predictions for VolitionRx LimitedQuick Profit Setup with Signal Forecast - Newser
Automated trading signals detected on VolitionRx LimitedFree AI Driven Buy Alert Trade Blueprint - Newser
Applying big data sentiment scoring on VolitionRx LimitedInvestment Timeline and ROI Summary Report - Newser
VolitionRx Limited Rebounds From Oversold Zone — Now WhatSwing Trading Plan With Smart Signals in Review - metal.it
Short Term Charts Align With Long Term Uptrend in VolitionRx LimitedBuy Alerts With Low Risk Confirmation Noted - beatles.ru
When is VolitionRx Limited stock expected to show significant growthAdvanced Screener Data Feed To Watch Now - Jammu Links News
What markets is VolitionRx Limited expanding into Is FOXO stock a good long term investment optionMassive stock growth - Jammu Links News
What are the latest earnings results for VolitionRx LimitedGet alerts on the hottest market movers - Jammu Links News
How many analysts rate VolitionRx Limited as a “Buy”Unlock daily market insights for better trades - Jammu Links News
Does VolitionRx Limited stock perform well during market downturnsAchieve rapid wealth accumulation with smart picks - Jammu Links News
Should I hold or sell VolitionRx Limited stock in 2025Jaw-dropping returns - Jammu Links News
What is the risk reward ratio of investing in VolitionRx Limited stockAchieve breakthrough investment performance - Jammu Links News
Buy Signal for VolitionRx Limited Stock Key Technical Indicators to WatchBig Return Stock Tips - Newser
Why VolitionRx Limited stock attracts strong analyst attentionProtected Capital Trading Plan - metal.it
How VolitionRx Limited stock performs during market volatilityFree Access to Community - Newser
What analysts say about VolitionRx Limited stockFree Stock Selection - PrintWeekIndia
VolitionRx Limited Stock Analysis and ForecastOutstanding capital growth - Jammu Links News
What analysts say about BGSF stockUnmatched profit growth - jammulinksnews.com
Is VolitionRx Limited a good long term investmentSky-high profits - jammulinksnews.com
What drives VolitionRx Limited stock pricePowerful profit generation - jammulinksnews.com
Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation - MarketScreener
VolitionRx Limited Announces Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - MarketScreener
Breakthrough: New 5-Minute Blood Test Could Transform Emergency Care and Sepsis Detection - Stock Titan
Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - Ariva
VolitionRx:Nu.Q advances in lung cancer management - research-tree.com
VNRX INVESTOR NOTICE: Kaskela Law LLC Announces Investigation of VolitionRx Ltd. (NYSE: VNRX) and Encourages Long-Term Investors to Contact the Firm - ACCESS Newswire
VolitionRx CEO Cameron Reynolds acquires $7,372 in common stock By Investing.com - Investing.com India
VolitionRX Ltd (VNRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
자본화:
|
볼륨(24시간):